Methods of treating heart failure with cardiac sarcomere activators
US11931358B2 · kind B2 · utility
6Cited by
24References
30Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 5, 2023 |
| Grant date | Mar 19, 2024 |
| Priority date | — |
| Expiry date | May 5, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are methods of treating a subject with heart failure, comprising administering to the subject an initial dose of a cardiac sarcomere activator (CSA) for an initial time period, and subsequently administering to the subject a dose of the CSA based on the subject's plasma concentration of the CSA at the end of the initial time period.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.